Table 2.xls (5.5 kB)
Number of adverse and serious adverse events of all studied patients.
dataset
posted on 2017-10-30, 17:37 authored by Dirk Schädler, Christine Pausch, Daniel Heise, Andreas Meier-Hellmann, Jörg Brederlau, Norbert Weiler, Gernot Marx, Christian Putensen, Claudia Spies, Achim Jörres, Michael Quintel, Christoph Engel, John A. Kellum, Martin K. KuhlmannNumber of adverse and serious adverse events of all studied patients.
History
Usage metrics
Categories
Keywords
patient morbiditylung injuryplasma IL -6 levelsIL -6hemoadsorption therapyPrimary outcomeplasma IL -6-levelsventilation timetrial Objective100 randomized patientsstudy day 160- day-mortalitytreatment periodbaseline imbalancesIL -6-serum concentrations6 hoursnovel extracorporeal cytokine hemoadsorption devicemulticenter trialreplacement therapy7. Results 97study inclusiondistress syndromeorgan dysfunction scorepatient populationorgan failureIL -6 eliminationCytoSorb hemoperfusiontime course
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC